Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Return on Sales (2020 - 2025)

Bioventus' Return on Sales history spans 5 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Sales changed N/A year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.05%, changed N/A, while the annual FY2023 figure was 0.15%, 1.0% down from the prior year.
  • Return on Sales reached 0.11% in Q4 2025 per BVS's latest filing, up from 0.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.3% in Q2 2021 to a low of 0.63% in Q2 2023.
  • Average Return on Sales over 4 years is 0.09%, with a median of 0.02% recorded in 2021.
  • Peak YoY movement for Return on Sales: rose 17bps in 2021, then crashed -62bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 0.0% in 2021, then crashed by -96890bps to 0.19% in 2022, then increased by 22bps to 0.15% in 2023, then skyrocketed by 175bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for BVS's Return on Sales are 0.11% (Q4 2025), 0.03% (Q3 2025), and 0.06% (Q2 2025).